CARDIAC SUPPORT:
Inotropes usage was more in EARLY MIS-N with 29(50%) neonates; IV Sildenafil was used only in 8(20%) neonates. Neonates with LATE MIS-N required inotropic support in 8(20%) neonates and IV Sildenafil in 4 (10%) neonates with PPHN.